RNA

Atrium Therapeutics, Inc.

Company with tickers: RNA

CIK

2093101

CUSIP

04965N104

Shares Outstanding

17,105,643

13F Activity (30d)

106 filings 106 filers

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value	After
2026-04-20	Hoyos Rocio Martin	Chief Strategy Officer	Award	60,000	—	—	60,000
2026-04-20	Hoyos Rocio Martin	Chief Strategy Officer	Award	30,000	—	—	46,660
2026-04-20	Hughes Steven George	Chief Development Officer	Award	30,000	—	—	73,097
2026-04-20	Winslow Brendan R.	Chief Financial Officer	Award	30,000	—	—	43,601
2026-04-20	Hughes Steven George	Chief Development Officer	Award	60,000	—	—	60,000
2026-04-20	Gallagher Kathleen P.	Director, See Remarks	Award	102,500	—	—	131,361
2026-04-20	Kenney Stephanie	See Remarks	Award	30,000	—	—	35,460
2026-04-20	Winslow Brendan R.	Chief Financial Officer	Award	60,000	—	—	60,000
2026-04-20	Kenney Stephanie	See Remarks	Award	60,000	—	—	60,000
2026-04-20	Gallagher Kathleen P.	Director, See Remarks	Award	205,000	—	—	205,000
2026-04-20	Younis Husam	Chief Scientific Officer	Award	30,000	—	—	52,657
2026-04-20	Younis Husam	Chief Scientific Officer	Award	60,000	—	—	60,000
2026-02-27	WILSON TROY EDWARD	Director	Award	20,000	—	—	20,000
2026-02-27	Skerjanec Simona	Director	Award	20,000	—	—	20,000
2026-02-27	Boyce Sarah	Director	Award	20,000	—	—	20,000
2026-02-27	BOESS CARSTEN	Director	Award	20,000	—	—	20,000
2026-02-27	Flanagan W. Michael	Director	Award	20,000	—	—	20,000
2026-02-26	Winslow Brendan R.	Chief Financial Officer	Other	13,601	—	—	13,601
2026-02-26	BOESS CARSTEN	Director	Other	11,005	—	—	11,005
2026-02-26	Boyce Sarah	Director	Other	265,086	—	—	265,086
2026-02-26	Flanagan W. Michael	Director	Other	54,786	—	—	54,786
2026-02-26	Gallagher Kathleen P.	Director, See Remarks	Other	28,861	—	—	28,861
2026-02-26	Younis Husam	Chief Scientific Officer	Other	22,657	—	—	22,657
2026-02-26	Hughes Steven George	Chief Development Officer	Other	43,097	—	—	43,097
2026-02-26	Hoyos Rocio Martin	Chief Strategy Officer	Other	16,660	—	—	16,660
2026-02-26	Kenney Stephanie	See Remarks	Other	5,460	—	—	5,460
2026-02-26	WILSON TROY EDWARD	Director	Other	10,360	—	—	10,360
2026-02-26	WILSON TROY EDWARD	Director	Other	1,371	—	—	1,371
2026-02-26	Skerjanec Simona	Director	Other	5,902	—	—	5,902

Showing 1–29 of 29 transactions